Skip to content

G7 Automated Hplc Analyzer, Beta-Thalassemia Mode

by Tosoh Medics, Inc.

510(k) K020489

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None ongoing

2 closed

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 9 Oct 2026. What this means

Regulatory status

as of registry sync 9 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK020489 Date14 May 2002ClearedStatusActive

Recalls

2 recalls · FDA

    • Terminated Z-3030-2011 FDA Unclassified (pre-2012) initiated 25 May 2011

    The value after reconstitution appeared to be lower than the assigned value on the label. The measured value for Lot BCAL05R was 5.3%, whereas the value on the label is 5.7%. The criteria of the value is +/- 0.3%.

    • Terminated Z-1075-2013 FDA Class III initiated 18 Aug 2010

    The Beta-thalessemia Mode of the G7 Analyzer-Beta Thalassemia Mode is an automated High Performance Liquid Chromatography (HPLC) system that separates and reports HbF and HbA2 quantitative percentages in whole blood. The firm received complaints that the A2 peak could not be detected with the G7 Beta-thalessemia columns.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
JPD
Device Class
Class II
Regulation
21 CFR Part 864.7400
Advisory Committee
Hematology
FDA Decision
SESE Substantially Equivalent

Other devices from Tosoh Medics, Inc.

See all devices from Tosoh Medics, Inc. →